Award notice Supplies
Intraveneuze immunoglobulinen
Notice published in Dutch. The AI analysis summarises it for you in your language.
- Public buyer
- AZ Delta vzw
Roeselare - Place of performance
- 8800 Roeselare, West Flanders
not published: buyer's address - Amount awarded
- €11,592,512 excl. VAT
- Planned end of contract
- 30 June 2030
likely re-tender around December 2029 - Bids received
- 3
- Form
- Framework agreement
Multi-year contract: the buyer places orders as needs arise. - Procedure
- Open procedure
Any company may submit a bid. - Publication
- 21 May 2026
- Notice language
- Dutch
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
Deze opdracht omvat het sluiten van een raamovereenkomst voor de levering van intraveneuze immunoglobulinen voor een periode van één jaar en driemaal stilzwijgend verlengbaar voor telkens één jaar.
Awarded to
- CSL Behring NV BCE/KBO 0454.483.701
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33651520
Winning prices for comparable contracts
- A quarter below
- €290,000
- Median
- €403,000
- A quarter above
- €1,351,075
Amounts awarded (excl. VAT) over the last 3 years for 5 contracts in the same CPV group (3365…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Similar contracts already awarded
| Contract | Winner | Amount |
|---|---|---|
| Antimycotica AZ Delta vzw · 21 October 2026 |
Arega Pharma NV Sandoz NV Fresenius Kabi NV Pfizer NV |
€300,945 |
| Immunoglobuline humaine normale pour administration intraveineuse Cliniques universitaires Saint Luc · 22 October 2026 |
CSL BEHRING | €16,277,080 |
| Purchase, storage and delivery of live attenuated homologous vaccine against Lumpy Skin Disease European Commission, DG SANTE - Health and Food Safety · 1 October 2026 |
Huvepharma EOOD | €2,385,950 |
| Raamovereenkomst voor het leveren van immunoglobulines IV 10% Universitair Ziekenhuis Gent · 24 September 2026 |
CSL BEHRING NV | €27,360,000 |
| Aankoop en levering van plasmaderivaten Algemeen Ziekenhuis Sint-Maria vzw · 15 September 2026 |
CSL BEHRING DEPARTEMENT CENTRAL DE FRACTIONNEMENT Prothya Biosolutions Netherlands B.V. OCTAPHARMA BENELUX |
€18,749,295 |
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 350002-2026.